Co-Diagnostics, Inc. to host booth at MEDICA 2021 in Düsseldorf, Germany
SALT LAKE CITY, November 15, 2021 / PRNewswire / – Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique and patented platform for the development of molecular diagnostic assays, today announced that it will hold a booth this week at MEDICA 2021 in Düsseldorf, Germany from November 15 to 18.
The show is expected to include around 2,900 exhibitors from 70 countries, returning for the first time to an in-person show after the start of the pandemic. The Company expects to take the opportunity to generate increased interest in its product line. in vitro diagnostic and research products for COVID-19 and other infectious diseases, and to present and promote its CoPrimer ™ technology and applications to a large audience of international participants. The stand will be hosted by representatives of the Company and its network of European distributors.
Attendees interested in learning more about the company and its products, including the rapid point-of-care and home-based PCR diagnostic platform currently in development, are invited to visit booth D11-2 in Hall 3.
To learn more about the fair, including in-person and virtual registration details, please visit https://www.medica-tradefair.com.
About Co-Diagnostics, Inc .:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets advanced diagnostic technology. The Company’s technology is used for tests designed using the detection and / or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in sectors other than infectious diseases and to authorize the use of these tests to specific customers.